03-Jun-2015, Spontaneous Serious report (Report duplicates -  BIOGEN: 201581062334)
A Physician reported the case of a 50-Years-old Male patient who received Copaxone (GLATIRAMER ACETATE, 
Product is a Teva product). 
The patient took Copaxone (GLATIRAMER ACETATE, Dosage information not provided).
While on the suspect medication(s), the patient experienced SUSPECT PML(Serious ) . 
At the time of the report the outcome of the AEs were:   SUSPECT PML : Unknown.
Action taken with suspect drugs: Copaxone - Unknown.
This case was considered serious based on the following criteria: (Other Serious (Important Medical Events))
Teva Comment:  GLATIRAMER ACETATE - malignancy. CAusality: not related.
Because this is a spontaneous case, regulatory distribution will be handled as though it is a related case.
Print Time: 13-JUN-2016 09:36 AM If a field is blank, there is no data for that field Page 4 of 457
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information